SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-004356
Filing Date
2020-05-01
Accepted
2020-05-01 17:10:24
Documents
12
Period of Report
2020-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_042720.htm   iXBRL 8-K 33461
  Complete submission text file 0001387131-20-004356.txt   215415

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20200427.xsd EX-101.SCH 3204
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20200427_lab.xml EX-101.LAB 35273
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20200427_pre.xml EX-101.PRE 23158
7 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_042720_htm.xml XML 3767
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 20841773
SIC: 2834 Pharmaceutical Preparations